Skip to main content
. 2016 Feb 16;30(2):117–121. doi: 10.1016/j.sjopt.2016.02.001

Table 3.

Protocol for Assessment of Hydroxychloroquine (Plaquenil®) Toxicity.

Date of examination: ________________________________________________
Date of initiation of therapy: ________________________________________________
Total cumulative dose: ________________________________________________
Diagnosis: ________________________________________________
________________________________________________
________________________________________________



Investigations: Right eye Left eye
 1. Visual acuity (corrected) _____________ ____________
 2. Funduscopy _____________ ____________
 3. Visual fields 10-2 (Fovea, OU) _____________ ____________
 4. Multifocal electroretinogram (ERG) _____________ ____________
 5. OCT (Macula) _____________ ____________
 6. Fundus photograph _____________ ____________
 7. Fundus autofluorescence _____________ ____________



Risk factors:
 1. Duration > 5 years Yes _________ No _________
 2. Daily dose >6.5 mg/kg/day of ideal weight Yes _________ No _________
 3. Renal or Hepatic disease Yes _________ No _________
 4. Age >60 years Yes _________ No _________
 5. Pre-existing macular disease Yes _________ No _________